These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 6327515)

  • 21. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
    Palmieri V; Devereux RB
    Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blood pressure, plasma volume, and catecholamine levels during enalapril therapy in blacks with hypertension.
    Freier PA; Wollam GL; Hall WD; Unger DJ; Douglas MB; Bain RP
    Clin Pharmacol Ther; 1984 Dec; 36(6):731-7. PubMed ID: 6094076
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of enalapril and eprosartan on the renal vascular nitric oxide system in human essential hypertension.
    Delles C; Jacobi J; John S; Fleischmann I; Schmieder RE
    Kidney Int; 2002 Apr; 61(4):1462-8. PubMed ID: 11918753
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bradykinin contributes to the systemic hemodynamic effects of chronic angiotensin-converting enzyme inhibition in patients with heart failure.
    Cruden NL; Witherow FN; Webb DJ; Fox KA; Newby DE
    Arterioscler Thromb Vasc Biol; 2004 Jun; 24(6):1043-8. PubMed ID: 15105283
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of systemic and regional hemodynamic effects of a diuretic, an angiotensin II receptor antagonist, and an angiotensin-converting enzyme inhibitor in conscious renovascular hypertensive rats.
    Wang YX; Gavras I; Wierzba T; Gavras H
    J Lab Clin Med; 1992 Mar; 119(3):267-72. PubMed ID: 1541876
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enalapril maleate versus captopril. A comparison of the hormonal and antihypertensive effects.
    Ayers CR; Baker KM; Weaver BA; Lehman MR
    Drugs; 1985; 30 Suppl 1():70-3. PubMed ID: 2994989
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Manidipine versus enalapril monotherapy in patients with hypertension and type 2 diabetes mellitus: a multicenter, randomized, double-blind, 24-week study.
    Luque Otero M; Martell Claros N;
    Clin Ther; 2005 Feb; 27(2):166-73. PubMed ID: 15811479
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antihypertensive effect of the new oral angiotensin converting enzyme inhibitor "MK-421".
    Gavras H; Biollaz J; Waeber B; Brunner HR; Gavras I; Davies RO
    Lancet; 1981 Sep; 2(8246):543-7. PubMed ID: 6116000
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overview: the role of angiotensin-converting enzyme inhibitors in cardiovascular therapy.
    Abrams WB; Davies RO; Ferguson RK
    Fed Proc; 1984 Apr; 43(5):1314-21. PubMed ID: 6323221
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical and hemodynamic experience with enalapril in congestive heart failure.
    Cody RJ
    Am J Cardiol; 1985 Jan; 55(2):36A-40A. PubMed ID: 2981464
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of enalapril, a new converting enzyme inhibitor, in hypertension.
    Ferguson RK; Vlasses PH; Swanson BN; Mojaverian P; Hichens M; Irvin JD; Huber PB
    Clin Pharmacol Ther; 1982 Jul; 32(1):48-53. PubMed ID: 6282527
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ACE inhibition with spirapril improves diastolic function at rest independent of vasodilation during treatment with spirapril in mild to moderate hypertension.
    Petersen JR; Drabaek H; Gleerup G; Mehlsen J; Petersen LJ; Winther K
    Angiology; 1996 Mar; 47(3):233-40. PubMed ID: 8638865
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of delapril plus manidipine compared with enalapril plus hydrochlorothiazide in mild to moderate essential hypertension: results of a randomized trial.
    Mugellini A; Dobovisek J; Planinc D; Cremonesi G; Fogari R
    Clin Ther; 2004 Sep; 26(9):1419-26. PubMed ID: 15531004
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enalapril (MK-421), a new angiotensin-converting enzyme inhibitor. Acute and chronic effects in heart failure.
    Dunkman WB; Wilen M; Franciosa JA
    Chest; 1983 Nov; 84(5):539-45. PubMed ID: 6313304
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Changes in the central hemodynamics during the treatment of hypertension with Renitec and its combination with hydrochlorothiazide].
    Malaia LT; Lapshina LA; Bil'chenko AV; Shkapo VL
    Lik Sprava; 1996; (7-9):57-60. PubMed ID: 9072267
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of angiotensin I-converting enzyme with S 9490: biochemical effects, interspecies differences, and role of sodium diet in hemodynamic effects.
    Laubie M; Schiavi P; Vincent M; Schmitt H
    J Cardiovasc Pharmacol; 1984; 6(6):1076-82. PubMed ID: 6084763
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enalapril and lisinopril in renovascular hypertension--antihypertensive and hormonal effects of two new angiotensin-converting-enzyme (ACE) inhibitors. A preliminary report.
    Karlberg BE; Fyhrquist F; Grönhagen-Riska C; Tikkanen I; Ohman KP
    Scand J Urol Nephrol Suppl; 1984; 79():103-6. PubMed ID: 6089307
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elevated Homocysteine Concentrations Decrease the Antihypertensive Effect of Angiotensin-Converting Enzyme Inhibitors in Hypertensive Patients.
    Qin X; Li Y; Sun N; Wang H; Zhang Y; Wang J; Li J; Xu X; Liang M; Nie J; Wang B; Cheng X; Li N; Sun Y; Zhao L; Wang X; Hou FF; Huo Y
    Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):166-172. PubMed ID: 27834686
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of enalapril maleate on blood pressure, renin-angiotensin-aldosterone system, and peripheral sympathetic activity in essential hypertension.
    Cerasola G; Cottone S; D'Ignoto G; Grasso L; Carone MB; Carapelle E; Contorno A
    Clin Ther; 1987; 9(4):390-9. PubMed ID: 3038326
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enalapril improves systemic and renal hemodynamics and allows regression of left ventricular mass in essential hypertension.
    Dunn FG; Oigman W; Ventura HO; Messerli FH; Kobrin I; Frohlich ED
    Am J Cardiol; 1984 Jan; 53(1):105-8. PubMed ID: 6318542
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.